Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) fell 4.3% on Wednesday . The stock traded as low as $18.00 and last traded at $18.00. 177 shares changed hands during trading, a decline of 92% from the average daily volume of 2,344 shares. The stock had previously closed at $18.80.
Shionogi & Co., Ltd. Stock Performance
The business has a fifty day moving average of $18.16 and a 200-day moving average of $19.29.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
Read More
- Five stocks we like better than Shionogi & Co., Ltd.
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
